Press release from Wave Life Sciences Ltd.
- Business
Announcement Date: October 16, 2024 (U.S. Time)
detail:A press release regarding the RestorAATion-2 clinical trial of WVE-006, targeting alpha-1 antitrypsin deficiency, has been issued by Wave, a key investment of our company. For more details, Here Read the original press release here.